(1R,4S,5R)-9-(4,5-Bishydroxymethylcyclopent-2-en-1-yl)-9H-adenine [(-)-BCA] has been synthesized from (-)-Corey lactone in 11 steps and shown to have potent and selective effects against human immunodeficiency virus type 1. The result demonstrated that the potent-HIV activity of racemic BCA obtained in our previous work is expressed solely by the (1R,4S,5R)-(-)-isomer.
(1R,4S,5R)-9-(4,5-双羟甲基环戊-2-烯-1-基)-9H-
腺嘌呤 [(-)-BCA] 从 (-)-
科里内酯出发,经过11步反应合成,并显示出对人类免疫缺陷病毒1型的强效和选择性抑制作用。结果显示,在我们之前工作中获得的消旋BCA的强效抗HIV活性仅由 (1R,4S,5R)-(-)-异构体表达。